Oncotarget
The cover for issue 57 of Oncotarget features Figure 2, "Overall survival analysis of GLUT1, PD-L1, and histologic architecture," by Chamseddin, et al.
Combatting PDAC with two tumor-targeting small RNAs |
https://doi.org/10.18632/oncotarget.27245 Andrea L. Kasinski |
5892-5893 |
PDF | How to cite | Order a Reprint |
Malignant ascites: a source of therapeutic protein against ovarian cancer? |
https://doi.org/10.18632/oncotarget.27185 Pascale Ribaux, Aurore Britan, Gabriele Thumann, Florence Delie, Patrick Petignat, and Marie Cohen |
5894-5905 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer |
https://doi.org/10.18632/oncotarget.27187 Yosuke Ooizumi, Hiroshi Katoh, Mitsuo Yokota, Masahiko Watanabe, and Keishi Yamashita |
5906-5918 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma |
https://doi.org/10.18632/oncotarget.27194 Shatha Albattal, Meshael Alswailem, Yosra Moria, Hindi Al-Hindi, Majed Dasouki, Mohamed Abouelhoda, Hala Aba Alkhail, Entissar Alsuhaibani, and Ali S. Alzahrani |
5919-5931 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer |
https://doi.org/10.18632/oncotarget.27219 Shiho Fukui, Kazunori Nagasaka, Yuko Miyagawa, Ryoko Kikuchi-Koike, Yoshiko Kawata, Ranka Kanda, Takayuki Ichinose, Takeru Sugihara, Haruko Hiraike, Osamu Wada-Hiraike, Yuko Sasajima, and Takuya Ayabe |
5932-5948 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Germline mutations in cancer-predisposition genes in patients with biliary tract cancer |
https://doi.org/10.18632/oncotarget.27224 Takeshi Terashima, Kumiko Umemoto, Hideaki Takahashi, Hiroko Hosoi, Erina Takai, Shunsuke Kondo, Yasunari Sakamoto, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Mitsuhito Sasaki, Masafumi Ikeda, Kazuaki Shimada, Shuichi Kaneko, Shinichi Yachida, Kokichi Sugano, Takuji Okusaka, and Chigusa Morizane |
5949-5957 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.27234 Bahir H. Chamseddin, Eunice E. Lee, Jiwoong Kim, Xiaowei Zhan, Rong Yang, Kathleen M. Murphy, Cheryl Lewis, Gregory A. Hosler, Suntrea T. Hammer, and Richard C. Wang |
5958-5969 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer |
https://doi.org/10.18632/oncotarget.27235 Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil McCarthy, and Siu Kwan Sze |
5970-5982 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells |
https://doi.org/10.18632/oncotarget.27236 Francina J. Dijk, Miriam van Dijk, Bram Dorresteijn, and Klaske van Norren |
5983-5992 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma |
https://doi.org/10.18632/oncotarget.27243 Qiang Qiu, Mengyuan Li, Linyu Yang, Minghai Tang, Li Zheng, Fang Wang, Huandi Qiu, Cailing Liang, Ning Li, Dongni Yi, Yuyao Yi, Cong Pan, Shengyong Yang, Lijuan Chen, and Yiguo Hu |
5993-6005 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells |
https://doi.org/10.18632/oncotarget.10298 Prachi Namjoshi, Lori Showalter, Brian J. Czerniecki, and Gary K. Koski |
6006-6020 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Splicing regulatory factors in breast cancer hallmarks and disease progression |
https://doi.org/10.18632/oncotarget.27215 Esmee Koedoot, Liesanne Wolters, Bob van de Water, and Sylvia E. Le Dévédec |
6021-6037 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report |
https://doi.org/10.18632/oncotarget.27203 Mayank Rao, Meenakshi Bhattacharjee, Scott Shepard, and Sigmund Hsu |
6038-6042 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening |
https://doi.org/10.18632/oncotarget.27256 Stefano Sestini, Mattia Boeri, Alfonso Marchiano, Giuseppe Pelosi, Carlotta Galeone, Carla Verri, Paola Suatoni, Nicola Sverzellati, Carlo La Vecchia, Gabriella Sozzi, and Ugo Pastorino |
6043-6043 |
Correction | PDF | How to cite |
Correction: Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis |
https://doi.org/10.18632/oncotarget.27257 Haiyan Tan, Chun Zeng, Junbo Xie, Norah J. Alghamdi, Ya Song, Hongbing Zhang, Aimin Zhou, and Di Jin |
6044-6044 |
Correction | PDF | How to cite |
Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation |
https://doi.org/10.18632/oncotarget.27258 Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, and Ann Marie Pendergast |
6045-6046 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC